Stock listing
NASDAQ:ECYT Endocyte Inc Stock
Follow Endocyte Inc into a list and get an email when it puts out news.
Last close · NASDAQ:ECYT
$23.99 USD
Close on Dec 20, 2018 · No longer trades
- Lowest – highest close
- $1.19 – $28.17 USDSince Feb 4, 2011 · lowest Aug 21, 2017 · highest Mar 21, 2014
Delisted NASDAQ:ECYT no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:ECYT
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Endocyte Inc on 6ix
- Decks
- 3 decks · latest Nov 5, 2018
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Merger or Acquisition (November 2018) | Merger or acquisition | 7 slides | Nov 5, 2018 |
| Merger or Acquisition (October 2018) | Merger or acquisition | 8 slides | Oct 18, 2018 |
| Technical Presentation (December 2011) | Technical | 17 slides | Dec 13, 2011 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Patrick Machado Other companies: Alumis Inc. (Independent Board Member · Since at least Jun 27, 2024); Xenon Pharmaceuticals Inc. (Director · Since at least Nov 5, 2020); Arcus Biosciences, Inc. (Board Member · Since at least Dec 10, 2019); Adverum Biotechnologies Inc (Director · Since at least Mar 14, 2017); Turnstone Biologics Corp. (Director · Jul 20, 2023 – Jul 20, 2023 · Past); Acelyrin, Inc. (Director · May 4, 2023 – May 21, 2025 · Past); Roivant Sciences Ltd. (Director · Oct 1, 2021 – Oct 1, 2021 · Past); Principia Biopharma Inc (Director · Jun 11, 2019 – Sep 28, 2020 · Past); Turning Point Therapeutics Inc (Director · May 13, 2019 – Aug 17, 2022 · Past); Sio Gene Therapies Inc (Director · Jul 17, 2017 – Jul 17, 2017 · Past); Rocket Pharmaceuticals, Inc. (Director · Aug 17, 2016 – Jun 20, 2017 · Past); Scynexis, Inc. (Director · Sep 24, 2015 – Jan 2, 2019 · Past); Chimerix Inc (Director · Jun 20, 2014 – Jun 9, 2023 · Past); Medivation Inc (Director · Jun 5, 2007 – Sep 28, 2016 · Past) | Director · Feb 27, 2018 – Dec 21, 2018 · Past |
| Dawn Svoronos Other companies: Adverum Biotechnologies Inc (Director · Since at least Dec 9, 2020); Xenon Pharmaceuticals Inc. (Director · Since at least Sep 27, 2016); Acelyrin, Inc. (Director · May 4, 2023 – May 21, 2025 · Past); Global Blood Therapeutics Inc (Director · Dec 19, 2018 – Oct 5, 2022 · Past); PTC Therapeutics, Inc. (Director · Jun 10, 2016 – Jun 9, 2022 · Past); Medivation Inc (Director · Apr 22, 2013 – Sep 28, 2016 · Past) | Director · May 3, 2018 – Dec 21, 2018 · Past |
| Fred A Middleton Other companies: CalciMedica, Inc. (Director · Since at least Mar 20, 2023); Chimerix Inc (Director · Mar 28, 2018 – Apr 21, 2025 · Past); Stereotaxis, Inc. (Director · Jan 3, 2012 – Mar 2, 2018 · Past); Pacira BioSciences, Inc. (Director · Nov 21, 2011 – Jun 21, 2013 · Past) | Director · Dec 16, 2011 – Dec 21, 2018 · Past |
| James Shannon Other companies: ProQR Therapeutics N.V. (Director · Since at least Mar 18, 2026); Xilio Therapeutics, Inc. (Board Member · Since at least Jun 13, 2024); MannKind Corporation (Chairman of the Board · Since at least Jun 10, 2010); Horizon Pharma PLC (Director · Aug 2, 2017 – Aug 2, 2018 · Past) | Director · Feb 4, 2011 – May 26, 2011 · Past |
| Beth Taylor Other companies: Inotiv, Inc. (Chief Financial Officer · Since at least May 7, 2021); Bioanalytical Systems Inc (VP- Finance & CFO · Mar 9, 2020 – Mar 5, 2021 · Past) | VP Finance & Chief Acctg Off · May 26, 2011 – Dec 21, 2018 · Past |
| Ann F. Hanham Other companies: Scynexis, Inc. (Director · Since at least May 2, 2014) | Director · May 14, 2013 – May 4, 2017 · Past |
| Christopher P Leamon Other companies: Fusion Pharmaceuticals Inc (Chief Scientific Officer · Nov 1, 2021 – Jun 4, 2024 · Past) | Vice President of Research · Dec 21, 2011 – Dec 21, 2018 · Past |
| Michael T Andriole Other companies: Chimerix Inc (PRESIDENT AND CEO, Director · Apr 8, 2019 – Apr 21, 2025 · Past) | Chief Financial Officer · Oct 4, 2017 – Dec 21, 2018 · Past |
| John C Aplin | Director · Feb 4, 2011 – Dec 21, 2018 · Past |
| Michael A Brinkley | Vice President of Quality · Jun 19, 2013 – Feb 4, 2017 · Past |
All 11 people
| Person | Seat |
|---|---|
| Scot Harper | VP of CLINICAL OPERATIONS · Feb 4, 2016 – Feb 4, 2016 · Past |
Log in to ask 6ix AI your own questions about Endocyte Inc.